1. DIGITAL.CSIC

Lazo, Pedro A.

Colaboraciones Ver estadísticas de uso Alertas por Email RSS

Perfil

Lazozb.jpg picture
 
Firma en Digital.CSIC (*)
Lazo, Pedro A.
 
Otras firmas
Lazo, Pedro
 
Centro o Instituto
CSIC-USAL - Instituto de Biología Molecular y Celular del Cancer de Salamanca (IBMCC)
 
Departamento
Laboratorio 14: Molecular an cellular bases of tumour progression and cancer stem cells. Grupo: Signalling by human serine-threonine kinases in cancer biology, neurodegeneration and DNA damage responses
 
Categoría Profesional
Profesor de Investigación
 
Especialización
Kinases in oncology
 
Email
plazozbi@usal.es
 
ORCID
 
Página web
 
Otros identificadores (con url)
 

Publications

Resultados 81-95 de 95.

DerechosPreviewFecha Public.TítuloAutor(es)Tipo
81openAccessvrkneurop.pdf.jpg2020VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathyMarcos, Ana T.; Martín-Doncel, Elena CSIC ORCID; Morejón-García, Patricia CSIC ORCID; Marcos-Alcalde, Íñigo CSIC ORCID; Gómez-Puertas, Paulino CSIC ORCID ; Segura‐Puimedon, María; Armengol, Lluís; Navarro‐Pando, José M.; Lazo, Pedro A. CSIC ORCID artículo
82openAccess2018VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosisMoura, David S. CSIC ORCID; Campillo-Marcos, Ignacio CSIC ORCID; Vázquez-Cedeira, Marta CSIC; Lazo, Pedro A. CSIC ORCID artículo
83openAccessEpigenetics 10, 373-383 (2015).pdf.jpgmay-2015VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damageSalzano, Marcella CSIC ORCID; Sanz-García, Marta CSIC; Monsalve, Diana M. CSIC; Moura, David S. CSIC ORCID; Lazo, Pedro A. CSIC ORCID artículo
84openAccessVRK1 Depletion_Navarro_PV_Art2021.pdf.jpgjun-2021VRK1 depletion facilitates the synthetic lethality of temozolomide and olaparib in glioblastoma cellsNavarro Carrasco, Elena CSIC ORCID; Lazo, Pedro A. CSIC ORCID artículo
85openAccess2019VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromesMartín-Doncel, Elena CSIC ORCID; Rojas Mendoza, Ana M. CSIC ORCID ; Cantarero, Lara CSIC ORCID; Lazo, Pedro A. CSIC ORCID artículo
86closedAccessaccesoRestringido.pdf.jpg2014VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damageLópez-Sánchez, Inmaculada CSIC; Valbuena, A.; Vázquez-Cedeira, Marta CSIC; Khadake, Jyoti; Sanz-García, Marta CSIC; Carrillo-Jiménez, Alejandro CSIC; Lazo, Pedro A. CSIC ORCID artículo
87openAccessVRK1_Kinase_Activity_Monte_Art_2023.pdf.jpg1-mar-2023VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1Monte-Serrano, Eva CSIC ORCID; Lazo, Pedro A. CSIC ORCID artículo
88openAccessBBA Mol Cell Res 1863 2016.pdf.jpgabr-2016VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damageMonsalve, Diana M. CSIC; Campillo-Marcos, Ignacio CSIC ORCID; Salzano, Marcella CSIC ORCID; Sanz-García, Marta CSIC; Cantarero, Lara CSIC ORCID; Lazo, Pedro A. CSIC ORCID artículo
89openAccessScientific Reports 5;10543 (2015).pdf.jpg29-jun-2015VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycleCantarero, Lara CSIC ORCID; Sanz-García, Marta CSIC; Vinograd-Byk, Hadar; Renbaum, Paul; Levy-Lahad, Ephrat; Lazo, Pedro A. CSIC ORCID artículo
90closedAccess2006VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinomaSantos, Claudio R.; Lazo, Pedro A. CSIC ORCID artículo
91openAccessVRK1_Lazo_Art_2023.pdf.jpgjul-2023VRK1 variants at the cross road of Cajal body neuropathogenic mechanisms in distal neuropathies and motor neuron diseasesLazo, Pedro A. CSIC ORCID ; Morejón-García, Patricia CSIC ORCIDartículo
92openAccessAtlas Genet Cytogenet Oncol Hematol 16; 841-843 (2012).pdf.jpg2012VRK2 (vaccinia related kinase 2)Vázquez-Cedeira, Marta CSIC; Blanco, Sandra CSIC ORCID CVN; Fernández, Isabel F. CSIC; Monsalve, Diana M. CSIC; Lazo, Pedro A. CSIC ORCID artículo
93closedAccessaccesoRestringido.pdf.jpg2012VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signalingFernández, Isabel F. CSIC; Blanco, Sandra CSIC ORCID CVN; Lazo, Pedro A. CSIC ORCID artículo
94openAccess1472-6890-13-23-S5.PDF.jpg1-oct-2013VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosisRodríguez-Hernández, Irene; Vázquez-Cedeira, Marta CSIC; Santos-Briz, Ángel; García, Juan L. CSIC ORCID CVN ; Fernández, Isabel F. CSIC; Gómez-Moreta, Juan A.; Martin-Vallejo, Javier; González-Sarmiento, Rogelio CSIC ORCID ; Lazo, Pedro A. CSIC ORCID artículo
95closedAccessaccesoRestringido.pdf.jpgoct-2010VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancerFernández, Isabel F. CSIC; Lazo, Pedro A. CSIC ORCID artículo